How is coronavirus affecting our operations? Learn more


Progress in Understanding Dyskinesia

Long-term use of L-DOPA (levodopa), the most effective treatment for Parkinson’s disease, commonly leads to a movement problem called dyskinesia, a side effect that can be as debilitating as Parkinson’s disease itself.The latest issue of Science Daily reports on the discovery by a team at Columbia University, New York, of the underlying mechanism. Using a…

Print this page

New therapeutic principle for dyskinesia shows clinical effect

Involuntary dyskinetic movements induced by treatment with levodopa (L-dopa) are a common problem for people with Parkinson’s disease. Science Today reports that researchers at Karolinska Institutet and Lund University in Sweden seem to be close to a novel therapy for this distressing side effect. A treatment study published in the scientific periodical Brain shows that…

Print this page
Back to top